List of Press Releases 

Stramsen Biotech Inc. Announced Eleven New Natural Plant-based Drug / Medicine Candidates During its Board Members' Meeting (prnewswire.com)

​

Stramsen Biotech, Inc Announces $10 Million Series Financing Round at $807 Million Valuation (prnewswire.com)

​

Stramsen Biotech Joins Elite Class of Unicorns at $6.5 Billion Valuation and a Potential Reverse Merger Deal (prnewswire.com)

​

Stramsen Biotech Inc. Announced Military Veteran Mr. Chris White -(MBA) as The New President and Chief Financial Officer (prnewswire.com)

​

​Stramsen Biotech Announces Partnership with Nasdaq Private Market (NPM) | FirstWord Pharma

​

Stramsen Biotech Inc. Announced Mr. Joe Meuth as The Chairman of the Board of Directors and Mr. Peter Olsen as President and CFO (prnewswire.com)

​

​

Stramsen Biotech Inc. Appoints Dr. Kefas (Ph.D.) and Christopher Ramirez as Co-CEOs for The New Biotech Company (prnewswire.com)

​

​

Stramsen Biotech, Inc Announces Six Drug / Medicine Candidates Currently in Early-Stage Clinical Trials (prnewswire.com)

 

​

​Stramsen Biotech Announces Partnership with Nasdaq Private Market (NPM) | Prnewswire | starlocalmedia.com

​

​

Stramsen Biotech is Valued at $19 Billion, Seeks Investment Banks and Law Firms, and Reserves SBRX as Its Trading Symbol

 

 

 

Stramsen Biotech Thanks the FDA for Their Review and Positive Feedback on Pre IND Application for SBX-1977 Wound Care Medicine

 

 

Stramsen Biotech Submits Pre-IND Package to FDA for SBX 1977 Wound Care Medicine, Requests Pre-IND Meeting and Phase 2 Trial

​

​​

​Stramsen Biotech Inc. Announced $25 Million Funding Commitment from GEM Global Yield LLC SCS ("GEM")